ReP USP - Resultado da busca

Artigo de periodico
MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin (2021)
Parente, Juliana Montenegro; Mello, Marcela Maria Blascke de ; Silva, Pedro Henrique Leite da; Omoto, Ana Carolina Mieko ; Pernomian, Laena; Oliveira, Isadora Sousa de; Mahmud, Zabed; Júnior, Rubens Fazan ; Arantes, Eliane Candiani ; Schulz, Richard; Castro, Michele Mazzaron de
Source: Biochemical Pharmacology. Unidades: FMRP, FCFRP
Subjects: HIPERTROFIA VENTRICULAR ESQUERDA, ANTIBIÓTICOS, REGULAÇÃO GÊNICA, HIPERTENSÃO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARENTE, Juliana Montenegro et al. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, v. 193, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114744. Acesso em: 01 nov. 2024.
APA
Parente, J. M., Mello, M. M. B. de, Silva, P. H. L. da, Omoto, A. C. M., Pernomian, L., Oliveira, I. S. de, et al. (2021). MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, 193, 1-13. doi:10.1016/j.bcp.2021.114744
NLM
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744
Vancouver
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744
Artigo de periodico
Reduced expression of adherens and gap junction proteins can have a fundamental role in the developmentof heart failure following cardiac hypertrophy in rats (2016)
Santos, Daniele O. dos; Blefari, Valdecir; Prado, Fernanda P.; Silva, Carlos A.; Fazan Júnior, Rubens; Salgado, Hélio César; Ramos, Simone Gusmão; Prado, Cibele Maria
Source: Experimental and Molecular Pathology. Unidade: FMRP
Subjects: HIPERTENSÃO, PROTEÍNAS, INSUFICIÊNCIA CARDÍACA, HIPERTROFIA VENTRICULAR ESQUERDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Daniele O. dos et al. Reduced expression of adherens and gap junction proteins can have a fundamental role in the developmentof heart failure following cardiac hypertrophy in rats. Experimental and Molecular Pathology, v. 100, n. 1, p. 167- 176, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.yexmp.2015.12.009. Acesso em: 01 nov. 2024.
APA
Santos, D. O. dos, Blefari, V., Prado, F. P., Silva, C. A., Fazan Júnior, R., Salgado, H. C., et al. (2016). Reduced expression of adherens and gap junction proteins can have a fundamental role in the developmentof heart failure following cardiac hypertrophy in rats. Experimental and Molecular Pathology, 100( 1), 167- 176. doi:10.1016/j.yexmp.2015.12.009
NLM
Santos DO dos, Blefari V, Prado FP, Silva CA, Fazan Júnior R, Salgado HC, Ramos SG, Prado CM. Reduced expression of adherens and gap junction proteins can have a fundamental role in the developmentof heart failure following cardiac hypertrophy in rats [Internet]. Experimental and Molecular Pathology. 2016 ; 100( 1): 167- 176.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.yexmp.2015.12.009
Vancouver
Santos DO dos, Blefari V, Prado FP, Silva CA, Fazan Júnior R, Salgado HC, Ramos SG, Prado CM. Reduced expression of adherens and gap junction proteins can have a fundamental role in the developmentof heart failure following cardiac hypertrophy in rats [Internet]. Experimental and Molecular Pathology. 2016 ; 100( 1): 167- 176.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.yexmp.2015.12.009
Artigo de periodico
Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension (2010)
Rizzi, Élen; Castro, Michele M.; Prado, Cibele M.; Silva, Carlos A.; Fazan Junior, Rubens; Rossi, Marcos Antonio; Tanus-Santos, José Eduardo; Gerlach, Raquel Fernanda
Source: Journal of Cardiac Failure. Unidades: FMRP, FORP
Subjects: HIPERTROFIA VENTRICULAR ESQUERDA, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIZZI, Élen et al. Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure, v. 16, n. 7, p. 599-608, 2010Tradução . . Acesso em: 01 nov. 2024.
APA
Rizzi, É., Castro, M. M., Prado, C. M., Silva, C. A., Fazan Junior, R., Rossi, M. A., et al. (2010). Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure, 16( 7), 599-608.
NLM
Rizzi É, Castro MM, Prado CM, Silva CA, Fazan Junior R, Rossi MA, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure. 2010 ; 16( 7): 599-608.[citado 2024 nov. 01 ]
Vancouver
Rizzi É, Castro MM, Prado CM, Silva CA, Fazan Junior R, Rossi MA, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinase inhibition improves cardiac dysfunction and remodeling in 2-kidney, 1-Clip hypertension. Journal of Cardiac Failure. 2010 ; 16( 7): 599-608.[citado 2024 nov. 01 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em